Rate My Professor Lucia Schweitzer

Schweitzer’s research specializations encompass lysosomal dysfunction in neurodegenerative diseases, particularly neuronal ceroid lipofuscinoses (Batten disease), including the functions of CLN5 and CLN6 proteins in synaptic integrity and glial-neuronal interactions. She has contributed to neuroproteomic studies on SARS-CoV-2 infection effects on brain cells, identifying overrepresented neurodegeneration pathways and disrupted metabolic processes, as detailed in the 2023 publication 'Neuroproteomic Analysis after SARS-CoV-2 Infection Reveals Overrepresented Neurodegeneration Pathways and Disrupted Metabolic Pathways' in Biomolecules. Another key contribution appears in the 2021 paper 'Deficiency of the Lysosomal Protein CLN5 Alters Synaptic Protein Levels but Does Not Affect Synaptic Ultrastructure or Synaptic Plasticity in Mouse Neocortex'. In 2017, she received a Lottery Health Research grant of $69,462 for her biochemical research. Schweitzer participated in BHRC and BRNZ-funded COVID-19 brain research projects in 2020 alongside colleagues like Dr. Indranil Basak and Professor Miguel Quiñones-Mateu. Previously, as Research Engagement Manager for Te Niwha (Manaaki Infectious Disease Platform), she facilitated collaborations. Her work has influenced advancements in brain health research, including presentations such as 'A bad influence: Do glia with defective lysosomes harm healthy neurons?' at the 2022 Australia and New Zealand Conference of Brain Research, and chairing sessions at various scientific symposia.